Growth Stock Analytics-High EPS and Relative Strength Stock Market Trading System Growth Stock Analytics-High EPS and Relative Strength Stock Market Trading System
Growth Stock Investing and Trading for Stock Market Investors - Since 1996 | MyStockScreen.com | Home | Join Now | Member Login | Refer a Friend | Contact Us
Your Best Source For Top Stock Picks, Stock Rankings, Stock Screening, Swing Trading, Market Direction and More...
HI-EPSRS
Screener
My Watch
List
Market
Direction
Industry
Map
My
Account
Help Logout
Symbol:
Enter Symbols Separated By Spaces.
Download All Symbols To Text/CSV

Top Picks Watch List
Dist.Days: SPY:4 DOW:4 QQQ:2

GSA Live Portfolio:
FNSR PRO
2022-11-08: We have a signal to move out of CASH and into FBSOX....Read more

HI-EPSRS Database Search Results   

Search Results      Stocks 1 through 1 of 1 shown        Download Search Results Symbols To Text/CSV

Staar Surgical Co (STAA)
Vital Signs
GSA
Rank

Stock Ranking
Earnings
Consistency

EPS Consistency Ranking

0.1/1.0
Sales
Consistency

Sales Consistency Ranking

0.7/1.0
Looks Like
A Winner?

Looks Like A Winner Ranking

5/10
Entry Risk
Above Support

Price Above Stop Loss Ranking

29%
Group
Action

Group Action Ranking

0
"Must Have"/Timing Factors
GSA
73.03
Acc Dist
1.75
Disc
0.00%
Avg Vol
132,900
Liquidity
0.37%
Below High
2.99%
Group Action
0
3-Month Trends of Key Indicators:
Fundamental/Technical Factors
Qrtly EPS
160%  40%
EPS Growth
0%
Sls Growth
7%
Proj Growth
N/A %
Anal. Rank
3.75
Shares
41.2M
Instit
78%
3-Month Trends of Key Indicators:
Looks Like a Winner?
STAA looks better than most Top Picks Winners* in 5 out of 10 key factors.
Accum/Dist: 1.75 (median winner: 1.53)
Above 40wkMA: 46% (median winner: 35%)
Instit. Ownership: 78% (median winner: 63%)
Liquidity: 0.37% (median winner: 1.18%)
Group Action: 0 (median winner: 20)
GSA Rank: 73.03 (winner: 75.66)
Sales Growth: 7% (median winner: 28%)
Below 52wk High: 2.99% (winner: 3.30%)
Relative Strength: 95 (winner: 96)
Avg Qrtly EPS: 100% (median winner: 68%)
Industry Group: 0. Medical Equipment Wholesale

Instit.   Insiders   Yahoo   Zacks   MSN   Google Finance   Daily Charts   Web Site

  • STAAR Surgical Announces Webcast of Upcoming Investor and Analyst Day on November 16, 2017 Wed, 15 Nov 2017 12:00:00 +0000
    MONROVIA, Calif., Nov. 15, 2017 /PRNewswire/ -- STAAR Surgical Company (STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will provide a webcast of President & CEO Caren Mason's presentation during its upcoming Investor and Analyst Day. STAAR Surgical will host an Investor and Analyst Day on Thursday, November 16, 2017 at the STAAR Surgical R&D Center. The Company will also provide a webcast beginning at 11 a.m. ET.
  • Edited Transcript of STAA earnings conference call or presentation 8-Nov-17 9:30pm GMT Tue, 14 Nov 2017 17:36:01 +0000
    Q3 2017 STAAR Surgical Co Earnings Call
  • Staar Surgical posts 3Q profit Wed, 08 Nov 2017 21:43:55 +0000
    The Monrovia, California-based company said it had net income of 3 cents per share. Earnings, adjusted for one-time gains and costs, came to 4 cents per share. The maker of implantable lenses posted revenue ...
  • STAAR Surgical Reports Third Quarter 2017 Results Wed, 08 Nov 2017 21:01:00 +0000
    MONROVIA, Calif. , Nov. 8, 2017 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye today ...
  • STAAR Surgical Company to Host Earnings Call Wed, 08 Nov 2017 17:50:00 +0000
    NEW YORK, NY / ACCESSWIRE / November 8, 2017 / STAAR Surgical Company (NASDAQ: STAA ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 8, 2017 at 4:30 PM Eastern ...
  • STAAR Surgical to Report Third Quarter Results on November 8, 2017 Wed, 25 Oct 2017 11:00:00 +0000
    MONROVIA, Calif. , Oct. 25, 2017 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, ...
  • STAAR Surgical Appoints Scott D. Barnes, M.D. as Chief Medical Officer Mon, 02 Oct 2017 11:00:00 +0000
    Distinguished Ophthalmology Clinician to Serve as Strategic Guide for STAAR's Medical & Professional Affairs as well as Product Development Pathways MONROVIA, Calif. , Oct. 2, 2017 /PRNewswire/ -- STAAR ...
  • STAAR Surgical Names Deborah Andrews as CFO Thu, 28 Sep 2017 14:20:00 +0000
    Surindra Mann Joins STAAR as Vice President, Global Financial Planning & Analysis MONROVIA, Calif. , Sept. 28, 2017 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer ...
  • Analysts Take Action on Health Care Stocks Tue, 26 Sep 2017 17:43:57 +0000
    AbbVie downgraded to Neutral, and Quest Diagnostics reduced to Market Perform
  • STAAR Surgical (STAA) Looks Good: Stock Adds 9.2% in Session Tue, 26 Sep 2017 12:37:12 +0000
    STAAR Surgical Company (STAA) was a big mover last session, as the company saw its shares rise over 9% on the day.

Stock Research
Weekly-1Yr Daily-3Mo Daily-6Mo Daily-1Yr
Daily-6Mo w/2-ATR Stops 3-ATR 4-ATR
Daily-1 Yr (opens in new window)
(Larger Charts. ATR=Average True Range)

Stock Research
Rel Str Acc/Dist Grp Action Instit Disc%

Quarterly EPS GrowthQuarterly Sales Growth
STAA EPS/Sales Growth STAA vs. Peers



*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.
Copyright © 1996-2024 Growth Stock Analytics, LLC. All rights reserved.  Site Map | Privacy Policy | Contact Us